Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 773136-66-6 | MDL No. : | MFCD06204769 |
Formula : | C9H8FIO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GHRYAGFJSZGCAQ-UHFFFAOYSA-N |
M.W : | 294.06 | Pubchem ID : | 24820419 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 55.2 |
TPSA : | 26.3 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.04 cm/s |
Log Po/w (iLOGP) : | 2.25 |
Log Po/w (XLOGP3) : | 2.89 |
Log Po/w (WLOGP) : | 3.03 |
Log Po/w (MLOGP) : | 3.52 |
Log Po/w (SILICOS-IT) : | 3.43 |
Consensus Log Po/w : | 3.02 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.63 |
Solubility : | 0.0693 mg/ml ; 0.000236 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.1 |
Solubility : | 0.232 mg/ml ; 0.00079 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.1 |
Solubility : | 0.0234 mg/ml ; 0.0000794 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.0 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | at 100℃; Inert atmosphere | Example 91N,N-Dibutyl-4-chloro- 1 -(2-((5)-3-(hydroxymethyl)- 1 ,2,3 ,4-tetrahydroisoquinoline-2- carbonyl)-4-(naphthalen-2-ylsulfonylcarbamoyl)phenyl)-5-methyl-lH-pyrazole-3- carboxamideIntermediate 91 A: Ethyl 2-fluo -5-iodobenzoate[00316] To a solution of 2-fluoro-5-iodobenzoic acid (Oakwood, 0.99 g, 3.72 mmol) in EtOH (7.4 mL) was added H2S04 (198 μ, 3.72 mmol). The resulting reaction mixture was stirred at 100 °C overnight and then concentrated in vacuo. The crude oil was purified using flash column chromatography (gradient from 0percent to 10percent EtOAc/hexanes) to give the title compound (916 mg, 84percent) as a colorless oil. XH NMR (CDC13) δ 8.24 (dd, J= 6.8, 2.4 Hz, 1H), 7.81 (ddd, J= 8.8, 4.5, 2.4 Hz, 1H), 6.93 (dd, J= 10.3, 8.6 Hz, 1H), 4.41 (q, J= 7.0 Hz, 2H), 1.42 (t, J= 7.2 Hz, 3H). |
[ 204257-72-7 ]
Methyl 2-fluoro-4-iodobenzoate
Similarity: 0.95
[ 1027513-46-7 ]
Methyl 3-fluoro-4-iodobenzoate
Similarity: 0.85
[ 1417190-32-9 ]
Ethyl 3-fluoro-6-iodo-2-methylbenzoate
Similarity: 0.85
[ 1202897-48-0 ]
Methyl 5-fluoro-2-iodobenzoate
Similarity: 0.84
[ 204257-72-7 ]
Methyl 2-fluoro-4-iodobenzoate
Similarity: 0.95
[ 1027513-46-7 ]
Methyl 3-fluoro-4-iodobenzoate
Similarity: 0.85
[ 1417190-32-9 ]
Ethyl 3-fluoro-6-iodo-2-methylbenzoate
Similarity: 0.85
[ 1202897-48-0 ]
Methyl 5-fluoro-2-iodobenzoate
Similarity: 0.84
[ 204257-72-7 ]
Methyl 2-fluoro-4-iodobenzoate
Similarity: 0.95
[ 1027513-46-7 ]
Methyl 3-fluoro-4-iodobenzoate
Similarity: 0.85
[ 1417190-32-9 ]
Ethyl 3-fluoro-6-iodo-2-methylbenzoate
Similarity: 0.85
[ 1202897-48-0 ]
Methyl 5-fluoro-2-iodobenzoate
Similarity: 0.84